Search

everythinglearnresearchcommunity

for

Search:↓

Shampoos have evolved into multifunctional products with patented innovations for different hair needs and can include medicinal herbs for hair and scalp health.

The document reviews patents on nanoparticle systems used to deliver drugs, discussing their creation, use in treatments, and commercial applications.

Stopping finasteride and closing PFO can help prevent strokes in young adults.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Patents don't guarantee money; inventors must work hard and stay involved.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

Women inventors focus more on women's health, but there are few of them.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Coffee and its by-products are promising for skin health benefits in cosmetics and help reduce environmental impact.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Jasmonic acid and its derivatives play important roles in plant health and have potential uses in medicine and agriculture.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

3D skin bioprinting, using skin bioinks like collagen and gelatin, is growing fast and could help treat wounds, burns, and skin cancers, as well as test cosmetics and drugs.

Drug repurposing shows promise for treating many medical conditions.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The document reviews 20 U.S. patents from July and August 2004 about new drug forms, cancer treatments, aroma chemicals, statin drugs, and various chemical production methods.

The compounds tested could potentially treat hair loss and alopecia.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.